期刊文献+
共找到9篇文章
< 1 >
每页显示 20 50 100
支气管哮喘患者行布地奈德联合宣肺止咳干喘方治疗的临床效果分析
1
作者 王欢欢 《中国科技期刊数据库 医药》 2024年第9期0065-0068,共4页
探讨布地奈德联合宣肺止咳干喘方治疗的应用流程、主要功能,明确其是否可以改善支气管哮喘患者的临床指标。方法 将我院2022年9月-2023年9月收治的80例支气管哮喘患者作为研究对象,分成两个涵盖对象数量一致、治疗方法不同的组别,包括... 探讨布地奈德联合宣肺止咳干喘方治疗的应用流程、主要功能,明确其是否可以改善支气管哮喘患者的临床指标。方法 将我院2022年9月-2023年9月收治的80例支气管哮喘患者作为研究对象,分成两个涵盖对象数量一致、治疗方法不同的组别,包括对照组(布地奈德治疗)与观察组(布地奈德联合宣肺止咳干喘方治疗),两个组别参与主体均为40例。结果 观察组治疗后的肺功能优于对照组(P<0.05);观察组治疗后的临床疗效为97.50%,明显高于对照组的80.00%(P<0.05);观察组的哮喘发作次数少于对照组、发作持续时间短于对照组(P<0.05)。结论 布地奈德联合宣肺止咳干喘方治疗属于一种效果显著、应用价值大的方式,有利于帮助部分支气管哮喘患者恢复健康、帮助部分患者缓解病情,使其肺功能有所好转,减少了其哮喘发作次数,避免患者发作持续很长时间。 展开更多
关键词 支气管哮 布地奈德 宣肺止咳干喘
下载PDF
基于网络药理学和分子对接技术探究麻干平喘制剂治疗咳嗽变异性哮喘的作用机制 被引量:1
2
作者 李昀泽 任铭 +2 位作者 张颖 周子齐 李国信 《辽宁中医药大学学报》 CAS 2024年第4期199-206,共8页
目的利用网络药理学和分子对接技术探究麻干平喘制剂治疗咳嗽变异性哮喘的有效成分及其作用机制。方法在TCMSP、Herb数据库中查询麻干平喘制剂中各组成药物的活性成分,在GeneCards、OMIM数据库中对咳嗽变异性哮喘的疾病靶点进行搜索,筛... 目的利用网络药理学和分子对接技术探究麻干平喘制剂治疗咳嗽变异性哮喘的有效成分及其作用机制。方法在TCMSP、Herb数据库中查询麻干平喘制剂中各组成药物的活性成分,在GeneCards、OMIM数据库中对咳嗽变异性哮喘的疾病靶点进行搜索,筛选疾病与药物共同的靶点;使用Cytoscape软件绘制药物-活性成分-靶点-疾病网络,String数据库构建疾病-药物互作蛋白网络图;运用R语言和Perl计算机程序语言实现GO以及KEGG富集分析,并对关键靶点进行分子对接验证。结果得到药物靶点124个,疾病靶点3383个,筛选出麻干平喘制剂治疗咳嗽变异性哮喘的有效靶点80个;由PPI分析得出作用力最强的蛋白包括AKT1、CASP3、JUN、ESR1等;有效的疗效机制可能与TNF信号通路、IL-17信号通路、Th1和Th2细胞分化、PI3K-Akt信号通路等通路有关。分子对接显示:核心化合物槲皮素、甘草查尔酮A、山柰酚、芒柄花黄素与PPARG、AKT1、JUN、CASP3、STAT3有良好的结合活性。结论麻干平喘制剂可通过多靶点、多途径发挥治疗咳嗽变异性哮喘的疗效作用,为麻干平喘制剂的临床开发以及应用提供了有力的理论依据。 展开更多
关键词 网络药理学 分子对接 咳嗽变异性哮 制剂
下载PDF
喘可治注射液治疗40例支气管哮喘的临床观察 被引量:6
3
作者 沈小珩 朱伟嵘 +4 位作者 许建中 郭元彪 郑岚 赵静 夏翔 《中成药》 CAS CSCD 北大核心 2002年第1期36-40,共5页
目的 :验证喘可治注射液治疗成人急慢性支气管哮喘的临床疗效。方法 :选择门诊、住院支气管哮喘患者 40例 ,其中急性期 2 0例为发作组 ;慢性期 2 0例为缓解组。发作期组 :肌肉注射喘可治注射液 ,每次 4mL ,每日 2次 ,14d为 1疗程。缓解... 目的 :验证喘可治注射液治疗成人急慢性支气管哮喘的临床疗效。方法 :选择门诊、住院支气管哮喘患者 40例 ,其中急性期 2 0例为发作组 ;慢性期 2 0例为缓解组。发作期组 :肌肉注射喘可治注射液 ,每次 4mL ,每日 2次 ,14d为 1疗程。缓解期组 :前 14d肌肉注射喘可治注射液 ,每次 4mL ,每日 2次 ;15~ 30d ,每次 2mL ,每日 1次 ;31~ 90d ,每次 2mL ,隔日 1次。 90d为 1疗程。观察治疗前后中医症状和体征变化及检查治疗前后肺功能CFEV1,PEF)、嗜酸性粒细胞疤对计数 (EOS)和血清免疫球蛋白 (IgE)。 结果 :喘可治注射液治疗成人支气管哮喘的中医证候疗效的总有效率 ,发作期组与缓解期组均为 85 % ,两组治疗前后比较有显著差异 ,P <0 .0 1。发作期病例平均起效时间 (19.10± 10 .42 )h ,平均缓解时间 (11.0 0± 1.80 )d。对缓解期病人能明显减少复发。临床验证中未发现该药有明显不良反应。结论 :喘可治注射液可治疗轻。 展开更多
关键词 支气管哮 可治注射液 补骨脂 干喘
下载PDF
蛙鸣粉对豚鼠小鼠平喘止咳化痰的作用
4
作者 王健民 楼兰花 +2 位作者 马毅强 别晓东 金仁炎 《中国实验方剂学杂志》 CAS 1998年第6期62-62,共1页
以疏风熄风中药为主组成复方蛙鸣粉,对其豚鼠小鼠的平喘止咳化痰作用,进行了实验研究。1卵蛋白过敏性哮喘实验选用健康豚鼠,雄性,体重150g~180g,以5%卵蛋白生理盐水1ml,腹腔及后腿肌注致敏,随机分成4组,分别为... 以疏风熄风中药为主组成复方蛙鸣粉,对其豚鼠小鼠的平喘止咳化痰作用,进行了实验研究。1卵蛋白过敏性哮喘实验选用健康豚鼠,雄性,体重150g~180g,以5%卵蛋白生理盐水1ml,腹腔及后腿肌注致敏,随机分成4组,分别为对照组,蛙鸣粉预防组,蛙鸣粉防治组... 展开更多
关键词 蛙鸣粉 干喘 药理 止咳 中药
下载PDF
龙倩玲辨证分型治疗咳喘经验 被引量:1
5
作者 赵珊珊 《实用中医内科杂志》 2017年第5期12-13,共2页
龙倩玲教授认为风为六淫之首,肺为娇脏,风邪犯肺为外感咳嗽常见初始病因,与肺、脾、肾关系密切。提出"辨证论治,标本兼顾"的独到见解,辨证以风邪犯肺、痰热伏肺、痰饮阻肺为主,多以宣肺解表为主,治疗不拘于肺,根据不同证型或... 龙倩玲教授认为风为六淫之首,肺为娇脏,风邪犯肺为外感咳嗽常见初始病因,与肺、脾、肾关系密切。提出"辨证论治,标本兼顾"的独到见解,辨证以风邪犯肺、痰热伏肺、痰饮阻肺为主,多以宣肺解表为主,治疗不拘于肺,根据不同证型或培土以生金,或宣散外邪与内调气机并用,或扶土以化痰,或温肾以消饮;在组方遣药配伍中重视疾病变化,合理加减,每获良效。 展开更多
关键词 风邪犯肺 麻黄汤 龙倩玲 老中医经验 中医药治疗
下载PDF
止咳定喘干糖浆治疗小儿肺炎喘嗽236例临床观察
6
作者 焦平 耿少怡 《现代中医》 1996年第1期18-18,共1页
关键词 止咳定糖浆 小儿 肺炎
原文传递
Inhibition of allergic responsiveness in a murine asthma model via IFN-γ transgene expression
7
作者 高占成 康禹 +3 位作者 徐钰 尚颖 改军 何权瀛 《Chinese Medical Journal》 SCIE CAS CSCD 2002年第10期30-34,144-145,共7页
To investigate adenoviral vector mediated exogenous gene expression in mouse lungs and the effect of mIFN γ transgene expression on allergen induced pulmonary eosinophil infiltration in a murine asthmatic model ... To investigate adenoviral vector mediated exogenous gene expression in mouse lungs and the effect of mIFN γ transgene expression on allergen induced pulmonary eosinophil infiltration in a murine asthmatic model Methods LacZ marker gene was transduced into CD 1 mouse airway epithelial cells by installation of a replication deficient adenovirus with LacZ gene (AdCMVLacZ) 5×10 9 plaque forming unit (pfu) in the intratrachea or nostril C57 mice were sensitized intraperitoneally and challenged by aerosol with ovalbumin (OVA) to produce an asthmatic model AdCMVmIFNγ 5×10 9 pfu was administered via nostril in asthmatic mice 48 h before OVA challenge Sera, bronchial alveolar lavage (BAL) and lungs were recovered 48 h after OVA challenge Results After administration with AdCMVLacZ by intratracheal installation or nose drop, the lungs revealed a high level of widespread LacZ transduction with X gal staining, mainly along airways IFN γ via adenoviral vector transduction could be overexpressed both in vitro and in vivo (1624 7±1321 5 pg/ml in BAL 96 h after AdCMVIFNγ infection) In AdCMVIFNγ treated asthmatic models, histological evaluation revealed marked suppression of eosinophil peribronchial and perivascular infiltration; the recoverable percentage of eosinophils in BAL was an average of 9 00%±4 58%, which was a statistically significant decrease versus that of the positive control group (75 13%±6 85%) ( P 【0 001) The total cell number in BAL ((145±55 6)×10 3 cells/ml) in AdCMVmIFNγ treated mice also was tremendously reduced compared to the positive control group ((216 6±71 1)×10 3 cells/ml) Conclusions Adenoviral vector was able to overexpress exogenous gene in murine lungs IFN γ overexpression via adenoviral vector in pulmonary epithelia in vivo can abrogate allergen induced eosinophilic infiltration in lungs in an asthmatic model, which may suggest a new preventively therapeutic method for cytokine immunogenetic transfer in allergic asthma 展开更多
关键词 gene therapy · adenoviral vector · inter feron type · asthma
全文增补中
Development of ciclesonide dry powder inhalers and the anti-asthmatic efficacy in guinea pigs
8
作者 刘菲 王桂玲 +7 位作者 张燕 门萤 杜举 居瑞军 张亮 应雪 吕万良 张强 《Journal of Chinese Pharmaceutical Sciences》 CAS 2011年第5期473-482,共10页
Ciclesonide is a new corticosteroid currently in clinical development for the treatment of asthma by oral inhalation. The objectives of the present study were to develop ciclesonide dry powder inhalers (DPIs, 80 μg... Ciclesonide is a new corticosteroid currently in clinical development for the treatment of asthma by oral inhalation. The objectives of the present study were to develop ciclesonide dry powder inhalers (DPIs, 80 μg) and investigate the anti-asthmatic effect in animals. For preparing a ciclesonide capsule-type DPI, sphere-shaped lactose was used as a diluent carrier, mixed with micronized ciclesonide, and filled into a capsule, and then put into a dry powder inhaler for oral inhalation. The asthmatic model was established with guinea pigs, and the therapeutic efficacy of ciclesonide was performed on the asthmatic guinea pig model. Results showed that the pulmonary deposition ratio of ciclesonide DPIs was approximately 26% and their content uniformity met the requirements of China Pharmacopoeia. The established pathological model exhibited the typical features of asthma with a widened pulmonary alveolar interval, narrowed alveolar space and detached bronchial mucosal epithelium with topical necrosis, goblet cell hyperplasia, and inflammatory cell infiltration. After treating with ciclesonide, the impaired indicators in asthmatic guinea pigs were significantly recovered or alleviated, exhibiting decreased total cells, decreased eosinophils and a decreased IL-5 level while there was an increased IFN-γ level in the bronchoalveolar lavage fluid (BALF). This study develops a new pulmonary ciclesonide delivery system for treating asthma, and proves the therapeutic efficacy in asthmatic guinea pigs. 展开更多
关键词 CICLESONIDE Dry powder inhalers ASTHMA IL-5 IFN-Γ
原文传递
Effects of Wuwei Dilong Decoction on Inflammatory Cells and Cytokines in Asthma Model Guinea Pigs 被引量:4
9
作者 李祥华 涂献玉 +5 位作者 张德新 许甲凤 王文英 张渊 杜亚明 王友京 《Journal of Traditional Chinese Medicine》 SCIE CAS CSCD 2009年第3期220-223,共4页
Objective: To explore the effects and the mechanism of Wuwei Dilong Decoction (五味地龙汤 Schisandra Fruit and Earthworm Decoction) for treatment of asthma. Methods: The asthma guinea pig model was established wit... Objective: To explore the effects and the mechanism of Wuwei Dilong Decoction (五味地龙汤 Schisandra Fruit and Earthworm Decoction) for treatment of asthma. Methods: The asthma guinea pig model was established with spray of ovalbumin (OVA). Fifteen days later, the guinea pigs were administered by intra-gastric perfusion of Wuwei Dilong Decoction once a day for 8 consecutive days. Blood samples were taken for testing the total leucocytes, eosinophil (EOS), lymphocytes, interferon-γ (IFN-γ) and leukotriene B4 (LTB4). Results: In the asthma model group, the total leucocytes, EOS and lymphocytes were all increased, with significant differences as compared with the different dosage Wuwei Dilong Decoction groups (P〈0.01 or P〈0.05). The serum LTB4 in the asthma model group was significantly increased and IFN-γ decreased. After administration of Wuwei Dilong Decoction of the large, medium and small dosages, LTB4 decreased, while IFN-7 increased (P〈0.05 or P〈0.01). Conclusion: Wuwei Dilong Decoction can inhibit infiltration and diffusion of the inflammatory cells in the asthma model guinea pigs, and regulate LTB4 and IFN-γ, which is probably one of the important mechanisms of Wuwei Dilong Decoction for relieving asthma. 展开更多
关键词 ASTHMA CYTOKINES TCM therapy Wuwei Dilong Decoction
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部